Share Prices & Company Research

Stockbroking

Syncona

Current Price 262.25p Bid 259.50p Ask 262.50p Change 2.34%
Last Updated: 20/01/2019 06:53. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Syncona Limited (formerly BACIT Limited) is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Its vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

Financial Highlights Year Ended 31/03/2018

Turnover
£0.00m
Operating Profit
£0.00m
Dividend Yield
0.00
Dividend Per Share
2.30
Dividend Cover
0.34
P/E Ratio
313.46

Key Personnel

Jeremy John Tigue
Non-Executive Chairman
Gian Piero Reverberi
Non-Executive Director
Dr Ellen Ruth Strahlman
Non-Executive Director
Nicholas David Moss
Non-Executive Director
Nigel John Keen
Non-Executive Director
Robert Hutchinson
Non-Executive Director
Thomas Alexander Gavin Henderson
Non-Executive Director

Stock Details

EPIC
SYNC
ISIN
GG00B8P59C08
Shares in Issue
661,222,309
Market cap
£1,616.69m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
262.50p
Bid Price
259.50p
Ask Price
262.50p
Volume
572987
Change Today
6.00p
% Change Today
2.34%
Open
252.50p
Previous Close
262.50p
Intraday High
262.50p
Intraday Low
252.50p
52 Week High
306.50p
52 Week Low
185.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Syncona Intra-day Chart

Syncona News

News in this section is provided by MoneyAM

Syncona portfolio company Autolus commences new clinical trial 03 Dec 2018 | 07:49 Syncona posts 33% jump in performance; to invest at top of guidance range 21 Nov 2018 | 07:39 Syncona portfolio company Nighstar books loss; starts new clinical trial 13 Nov 2018 | 07:41 Syncona confirms $18m investment in retinal diseases group Nightstar 03 Oct 2018 | 07:23 Syncona invests $18m in Nightstar as part of public share offer 28 Sep 2018 | 07:42 Syncona company Nightstar reports positive eye treatment trial data 24 Sep 2018 | 09:14 Syncona portfolio company Nightstart posts quarterly loss 13 Aug 2018 | 13:18 Director Deals - Syncona Ltd (SYNC) 30 Jul 2018 | 16:15 Director Deals - Syncona Ltd (SYNC) 30 Jul 2018 | 16:15 FTSE soars as BP and Shell rally on higher oil prices 22 Jun 2018 | 16:53 FTSE given a boost by banks, miners and oil majors 22 Jun 2018 | 11:52 Syncona company Autolus Therapeutics prices US IPO 22 Jun 2018 | 07:15 Syncona offers £85m funding injection to gene therapy group Freeline 19 Jun 2018 | 07:18 Syncona delivers strong returns and an increase in NAV 14 Jun 2018 | 08:13 Syncona reaps benefits from Autolus Therapeutics IPO 08 Jun 2018 | 14:36 Syncona company Blue Earth Diagnostics inks imaging technology agreement 02 May 2018 | 07:43 Syncona revamps management structure to save on fee payments 09 Mar 2018 | 07:18 Syncona portfolio company Autolus files for IPO in the US 06 Mar 2018 | 07:56 Syncona company Nightstar starts clinical trial on choroideremia treatment 05 Mar 2018 | 13:17

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Tangible Assets
0.0
0.0
Intangible Assets & Goodwill
0.0
0.0
Investments & Other Non-Current Assets
1,064.5
896.5
Total Non-Current Assets
1,064.5
896.5
Inventory
0.0
0.0
Trade & Receivables
5.5
4.8
Cash & Receivables
1.0
0.1
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
1,071.0
901.4

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Short Term Liabilities
10.7
6.1
Long Term Liabilities
4.5
0.1
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
15.2
6.1

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Net Assets
1,055.8
895.2

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Share Capital
763.0
760.3
Minority Interests
0.0
0.0
Retained Earnings
0.0
0.0
Share Premium Account
0.0
0.0
Other Equity
292.8
134.9
Total Equity
1,055.8
895.2

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Cashflow from Operating Activities
8.2
7.1
Cashflow Before Financing
13.3
-158.1
Increase / Decrease in Cash
0.9
0.1

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Turnover
0.0
0.0
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
0.0
0.0
Pre-Tax Profit
160.0
136.0
Profit / Loss for the Year
0.0
0.0

Dividend History

Data has been provided by MoneyAM

Period
Ex-Dividend Date
Payment Date
H2 Dividend
21 Jun 2018
30 Jul 2018
H2 Dividend
20 Jul 2017
23 Aug 2017
H2 Dividend
14 Jul 2016
19 Aug 2016
H2 Dividend
16 Jul 2015
19 Aug 2015
H1 Dividend
06 Aug 2014
10 Sep 2014
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.